{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:48:35Z","timestamp":1792540115216,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.biopsych.2010.12.005","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T04:15:35Z","timestamp":1296792935000},"page":"1075-1082","source":"Crossref","is-referenced-by-count":35,"title":["A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo"],"prefix":"10.1016","volume":"69","author":[{"given":"Dahlia","family":"Garza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.12.005_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2010.12.005_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2010.12.005_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2010.12.005_bib4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2010.12.005_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.clinthera.2007.06.012","article-title":"Efficacy and tolerability of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose\u2013response study with 40-week follow-up for smoking cessation in Japanese smokers","volume":"29","author":"Nakamura","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.biopsych.2010.12.005_bib6","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1185\/03007990802177523","article-title":"The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: A randomized controlled trial","volume":"24","author":"Niaura","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.biopsych.2010.12.005_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2010.12.005_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.clinthera.2007.06.011","article-title":"A randomized, placebo-controlled trial of varenicline, a selective \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers","volume":"29","author":"Tsai","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.biopsych.2010.12.005_bib9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1843.2008.01476.x","article-title":"Varenicline for smoking cessation: A placebo-controlled, randomized study","volume":"14","author":"Wang","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.biopsych.2010.12.005_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11319180-000000000-00000","article-title":"Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: A pooled analysis","volume":"33","author":"Tonstad","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.biopsych.2010.12.005_bib12","doi-asserted-by":"crossref","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: A cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2010.12.005_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00427451","article-title":"Tobacco withdrawal symptoms: An experimental analysis","volume":"84","author":"Hatsukami","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2010.12.005_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1037\/0893-164X.21.2.127","article-title":"Measurement of the effects of abstinence from tobacco: A qualitative review","volume":"21","author":"Hughes","year":"2007","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.biopsych.2010.12.005_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: Valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.biopsych.2010.12.005_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14622200701188927","article-title":"Effects of abstinence from tobacco: Etiology, animal models, epidemiology, and significance: A subjective review","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.biopsych.2010.12.005_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.12.005_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2105\/AJPH.83.2.249","article-title":"Smoking and suicide among nurses","volume":"83","author":"Hemenway","year":"1993","journal-title":"Am J Public Health"},{"key":"10.1016\/j.biopsych.2010.12.005_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2008.06.003","article-title":"Smoking and suicide: A brief overview","volume":"98","author":"Hughes","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2010.12.005_bib20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/oxfordjournals.aje.a010148","article-title":"Cigarette smoking and suicide: A prospective study of 300,000 male active-duty Army soldiers","volume":"151","author":"Miller","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biopsych.2010.12.005_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2105\/AJPH.90.5.768","article-title":"Cigarettes and suicide: A prospective study of 50,000 men","volume":"90","author":"Miller","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.biopsych.2010.12.005_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: A revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"key":"10.1016\/j.biopsych.2010.12.005_bib25","series-title":"User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.biopsych.2010.12.005_bib26","series-title":"User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-1 Clinician Version","author":"First","year":"1997"},{"key":"10.1016\/j.biopsych.2010.12.005_bib27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/appi.ajp.164.7.1035","article-title":"Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.12.005_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/107319110100800409","article-title":"The Suicidal Behaviors Questionnaire\u2014Revised (SBQ-R): Validation with clinical and nonclinical samples","volume":"8","author":"Osman","year":"2001","journal-title":"Assessment"},{"key":"10.1016\/j.biopsych.2010.12.005_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.12.005_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.biopsych.2010.12.005_bib31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1177\/0091270006292624","article-title":"Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers","volume":"46","author":"Faessel","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2010.12.005_bib32","first-page":"343","article-title":"SAFTEE: A technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2010.12.005_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/10826087509026739","article-title":"Mood, primary heroin withdrawal, and acute methadone administration","volume":"10","author":"Price","year":"1975","journal-title":"Int J Addict"},{"key":"10.1016\/j.biopsych.2010.12.005_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-200102000-00014","article-title":"The relationship between mood state and plasma methadone concentration in maintenance patients","volume":"21","author":"Dyer","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.12.005_bib35","first-page":"S44","article-title":"Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior","volume":"3","author":"Coccaro","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2010.12.005_bib36","series-title":"EITS Manual for the Profile of Mood States","author":"McNair","year":"1992"},{"key":"10.1016\/j.biopsych.2010.12.005_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1185\/030079905X43712","article-title":"Revealing the multidimensional framework of the Minnesota Nicotine Withdrawal Scale","volume":"21","author":"Cappelleri","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.biopsych.2010.12.005_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7","article-title":"Adult and geriatric normative data and validation of the profile of mood states","volume":"55","author":"Nyenhuis","year":"1999","journal-title":"J Clin Psychol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231001276X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231001276X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T21:29:41Z","timestamp":1543958981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632231001276X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S000632231001276X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.12.005","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}